139 related articles for article (PubMed ID: 3048002)
1. Immunohistochemical study of medullary thyroid carcinoma: relationship of clinical features to prognostic factors in 36 patients.
Takami H; Bessho T; Kameya T; Mimura T; Ito K; Abe O; Hosoda Y; Shikata J
World J Surg; 1988 Aug; 12(4):572-9. PubMed ID: 3048002
[No Abstract] [Full Text] [Related]
2. Proliferating cell nuclear antigen (PCNA) in medullary thyroid carcinoma.
Skopelitou A; Korkolopoulou P; Papanikolaou A; Hadjiyannakis M
J Cancer Res Clin Oncol; 1993; 119(7):379-81. PubMed ID: 8098331
[TBL] [Abstract][Full Text] [Related]
3. Relationship of CD15 immunoreactivity and prognosis in sporadic medullary thyroid carcinoma.
Neuhold N; Längle F; Gnant M; Hollenstein U; Niederle B
J Cancer Res Clin Oncol; 1992; 118(8):629-34. PubMed ID: 1355485
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of Leu-M1 immunostaining in papillary carcinomas of the thyroid gland.
Schröder S; Schwarz W; Rehpenning W; Löning T; Böcker W
Virchows Arch A Pathol Anat Histopathol; 1987; 411(5):435-9. PubMed ID: 3116758
[TBL] [Abstract][Full Text] [Related]
5. [Evaluation of small-cell and spindle-cell thyroid tumors using immunohistochemical markers (retrospective study)].
Macák J
Cesk Patol; 1993 Feb; 29(1):11-4. PubMed ID: 8387395
[TBL] [Abstract][Full Text] [Related]
6. Thyroid antibodies.
Sobrinho-Simões M; Nesland JM; Johannessen JV
Am J Surg Pathol; 1987 Oct; 11(10):821-4. PubMed ID: 3661825
[No Abstract] [Full Text] [Related]
7. [Proliferating cell nuclear antigen/cyclin (PCNA/Cyclin) in thyroid carcinoma].
Xu YJ
Zhonghua Wai Ke Za Zhi; 1993 Oct; 31(10):628-9. PubMed ID: 7913437
[TBL] [Abstract][Full Text] [Related]
8. Association between the HLA-G molecule and lymph node metastasis in papillary thyroid cancer.
Nunes LM; Ayres FM; Francescantonio IC; Saddi VA; Avelino MA; Alencar Rde C; Silva RC; Meneghini AJ; Wastowski IJ
Hum Immunol; 2013 Apr; 74(4):447-51. PubMed ID: 23261411
[TBL] [Abstract][Full Text] [Related]
9. HLA and thyroid carcinoma.
Ahuja S; Hoppe I; von Keyserlingk H; Ernst H
Exp Clin Endocrinol; 1992; 99(3):134-6. PubMed ID: 1526261
[TBL] [Abstract][Full Text] [Related]
10. CD1a-positive dendritic cell density predicts disease-free survival in papillary thyroid carcinoma.
Hilly O; Rath-Wolfson L; Koren R; Mizrachi A; Hamzany Y; Bachar G; Shpitzer T
Pathol Res Pract; 2015 Sep; 211(9):652-6. PubMed ID: 26073685
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of histological and immunohistochemical characteristics for predicting the recurrence of medullary thyroid carcinoma.
Ríos A; Rodríguez JM; Acosta JM; Balsalobre MD; Torregrosa N; Sola J; Pérez-Flores D; Parrilla P
Ann Surg Oncol; 2010 Sep; 17(9):2444-51. PubMed ID: 20224859
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemistry in medullary thyroid carcinoma: prognosis and distinction between hereditary and sporadic tumors.
Franc B; Caillou B; Carrier AM; Dutrieux-Berger N; Floquet J; Houcke M; Justrabo E; Lange F; Pages A; Rigaud C
Henry Ford Hosp Med J; 1987; 35(2-3):139-42. PubMed ID: 2891646
[No Abstract] [Full Text] [Related]
13. Prognostic value of change in anti-thyroglobulin antibodies after thyroidectomy in patients with papillary thyroid carcinoma.
Ernaga-Lorea A; Hernández-Morhain MC; Anda-Apiñániz E; Pineda-Arribas JJ; Migueliz-Bermejo I; Eguílaz-Esparza N; Irigaray-Echarri A
Clin Transl Oncol; 2018 Jun; 20(6):740-744. PubMed ID: 29071517
[TBL] [Abstract][Full Text] [Related]
14. Evidence of vascular differentiation in anaplastic tumours of the thyroid--an immunohistological study.
Eckert F; Schmid U; Gloor F; Hedinger C
Virchows Arch A Pathol Anat Histopathol; 1986; 410(3):203-15. PubMed ID: 3099463
[TBL] [Abstract][Full Text] [Related]
15. Medullary thyroid cancer. An immunohistochemical and humoral study using six separate antigens.
Pacini F; Basolo F; Elisei R; Fugazzola L; Cola A; Pinchera A
Am J Clin Pathol; 1991 Mar; 95(3):300-8. PubMed ID: 1996540
[TBL] [Abstract][Full Text] [Related]
16. The relation of susceptibility to and biologic behavior of thyroid epithelial cell cancer to HLA-DR1.
Juhasz F; Balázs G; Stenszky V; Kozma L; Farid NR
Cancer; 1986 Jul; 58(1):52-4. PubMed ID: 3486708
[TBL] [Abstract][Full Text] [Related]
17. [Medullary thyroid carcinoma. Immunohistochemical markers in histopathology and research].
Schmid KW; Böcker W
Zentralbl Pathol; 1993 Jun; 139(2):115-29. PubMed ID: 8369268
[TBL] [Abstract][Full Text] [Related]
18. The role of immunoperoxidase techniques on paraffin embedded tissue in determining the histogenesis of undifferentiated thyroid neoplasms.
Myskow MW; Krajewski AS; Dewar AE; Millar EP; McLaren K; Fabre JW
Clin Endocrinol (Oxf); 1986 Mar; 24(3):335-41. PubMed ID: 2423275
[TBL] [Abstract][Full Text] [Related]
19. Carcinoembryonic antigen and nonspecific cross-reacting antigen in thyroid cancer. An immunocytochemical study using polyclonal and monoclonal antibodies.
Schröder S; Klöppel G
Am J Surg Pathol; 1987 Feb; 11(2):100-8. PubMed ID: 2433953
[TBL] [Abstract][Full Text] [Related]
20. [The importance of S-100 protein positive Langerhans cells and Leu-M1 positive tumor cells for prognosis of papillary thyroid cancer].
Willgeroth C; Floegel R; Rösler B
Zentralbl Chir; 1992; 117(11):603-6. PubMed ID: 1361703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
